Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Cervical Cancer

  Free Subscription


26.02.2024

1 Am J Nurs
1 Am J Obstet Gynecol
1 Am J Pathol
1 Am J Prev Med
1 Ann Diagn Pathol
1 Appl Biochem Biotechnol
1 Appl Microbiol Biotechnol
1 Biology (Basel)
1 Biomarkers
2 BMC Cancer
1 BMC Genomics
1 BMC Infect Dis
2 BMC Public Health
2 BMC Womens Health
1 Br J Cancer
1 Cancer Biol Ther
2 Cancer Cell Int
1 Chin Herb Med
1 Clin Cancer Res
2 Cureus
1 Curr Med Imaging
1 Data Brief
1 Ethiop J Health Sci
1 Eur J Cancer
1 Expert Opin Biol Ther
1 Fam Community Health
1 Front Cardiovasc Med
1 Front Med (Lausanne)
1 Front Microbiol
1 Front Public Health
2 Gynecol Oncol
1 Gynecol Oncol Rep
1 Hum Vaccin Immunother
1 Int J Gen Med
1 Int J Gynecol Cancer
1 Int J Surg
1 Int Wound J
1 J Cancer Res Clin Oncol
6 J Cancer Res Ther
1 J Gynecol Oncol
1 J Hematop
2 J Med Screen
1 J Med Virol
1 J Nutr
1 J Robot Surg
1 JCO Glob Oncol
1 Jpn J Clin Oncol
1 Lancet Glob Health
1 Lasers Med Sci
1 Mol Oncol
1 N Z Med J
1 Oncol Lett
1 PLoS One
1 Public Health
1 Rev Med Virol
1 Sci Rep
1 Virulence
1 Womens Health Issues
1 World J Surg Oncol
1 Zhonghua Fu Chan Ke Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Nurs


  1. News Brief: A quarter of U.S. women are not up to date on cervical cancer screening.
    Am J Nurs. 2024;124:11.
    PubMed        


    Am J Obstet Gynecol

  2. JORGENSEN KA, Agusti N, Wu CF, Kanbergs A, et al
    Fertility-sparing surgery versus standard surgery for early-stage cervical cancer: difference in 5-year life expectancy by tumor size.
    Am J Obstet Gynecol. 2024 Feb 14:S0002-9378(24)00084.
    PubMed         Abstract available


    Am J Pathol

  3. MASUDA M, Iida K, Iwabuchi S, Tanaka M, et al
    Clonal Origin and Lineage Ambiguity in Mixed Neuroendocrine Carcinoma of the Uterine Cervix.
    Am J Pathol. 2024;194:415-429.
    PubMed         Abstract available


    Am J Prev Med

  4. PARKER SL, Amboree TL, Bulsara S, Daheri M, et al
    Self-Sampling for Human Papillomavirus Testing: Acceptability in a U.S. Safety Net Health System.
    Am J Prev Med. 2024;66:540-547.
    PubMed         Abstract available


    Ann Diagn Pathol

  5. KUZUCULAR E, Ozden F, Muezzinoglu B
    Comparison of liquid-based cytology and cell blocks prepared from cell remnants for diagnosis of cervical pathology.
    Ann Diagn Pathol. 2024;69:152265.
    PubMed         Abstract available


    Appl Biochem Biotechnol

  6. GIRIJA NS, Neethi B, Sakthimanipriya L, Sinekha MA, et al
    In-Vitro Cytotoxic, Antiproliferative and Apoptotic Activity of Siddha Formulation Nandhi Mezhugu (NM) Against Hela Cell Line.
    Appl Biochem Biotechnol. 2024;196:1612-1622.
    PubMed         Abstract available


    Appl Microbiol Biotechnol

  7. ZHOU X, Wang Y, Bao M, Chu Y, et al
    Advanced detection of cervical cancer biomarkers using engineered filamentous phage nanofibers.
    Appl Microbiol Biotechnol. 2024;108:221.
    PubMed         Abstract available


    Biology (Basel)

  8. ROSENDO-CHALMA P, Antonio-Vejar V, Ortiz Tejedor JG, Ortiz Segarra J, et al
    The Hallmarks of Cervical Cancer: Molecular Mechanisms Induced by Human Papillomavirus.
    Biology (Basel). 2024;13:77.
    PubMed         Abstract available


    Biomarkers

  9. KAUR JAWANDA I, Soni T, Kumari S, Prabha V, et al
    Deciphering the potential of proteomic-based biomarkers in women's reproductive diseases: empowering precision medicine in gynecology.
    Biomarkers. 2024;29:7-17.
    PubMed         Abstract available


    BMC Cancer

  10. NAKIGOZI H, Ndejjo R, Bazeyo W, Nabaggala A, et al
    Prevalence of genital high-risk human papillomavirus infections and associated factors among women living with human immunodeficiency virus in Uganda.
    BMC Cancer. 2024;24:243.
    PubMed         Abstract available

  11. CORREDOR C, Pineros M, Wiesner C, de Vries E, et al
    Using administrative registries as a source for population-based cancer incidence and mortality.
    BMC Cancer. 2024;24:232.
    PubMed        


    BMC Genomics

  12. WANG Z, Liu C, Liu W, Lv X, et al
    Long-read sequencing reveals the structural complexity of genomic integration of HPV DNA in cervical cancer cell lines.
    BMC Genomics. 2024;25:198.
    PubMed         Abstract available


    BMC Infect Dis

  13. LU Y, Wu Q, Wang L, Ji L, et al
    Chlamydia trachomatis enhances HPV persistence through immune modulation.
    BMC Infect Dis. 2024;24:229.
    PubMed         Abstract available


    BMC Public Health

  14. MANTULA F, Toefy Y, Sewram V
    Barriers to cervical cancer screening in Africa: a systematic review.
    BMC Public Health. 2024;24:525.
    PubMed         Abstract available

  15. OKO-OBOH GA, Auvinen A, Obaseki DE, Pitkaniemi J, et al
    Improving cancer incidence evaluation through local government area matching: a study of the Edo-Benin cancer registry in Nigeria.
    BMC Public Health. 2024;24:514.
    PubMed         Abstract available


    BMC Womens Health

  16. EKAWATI FM, Listiani P, Idaiani S, Thobari JA, et al
    Cervical cancer screening program in Indonesia: is it time for HPV-DNA tests? Results of a qualitative study exploring the stakeholders' perspectives.
    BMC Womens Health. 2024;24:125.
    PubMed         Abstract available

  17. SUKRONG M, Prapaisilp P, Juntamongkol T, Siranart N, et al
    Knowledge regarding human papillomavirus and cervical cancer prevention among medical students from Chulalongkorn University in Thailand.
    BMC Womens Health. 2024;24:129.
    PubMed         Abstract available


    Br J Cancer

  18. DOWNHAM L, Jaafar I, Rol ML, Nyawira Nyaga V, et al
    Accuracy of HPV E6/E7 oncoprotein tests to detect high-grade cervical lesions: a systematic literature review and meta-analysis.
    Br J Cancer. 2023 Nov 16. doi: 10.1038/s41416-023-02490.
    PubMed         Abstract available


    Cancer Biol Ther

  19. WANG YY, Ye LH, Zhao AQ, Gao WR, et al
    M6A modification regulates tumor suppressor DIRAS1 expression in cervical cancer cells.
    Cancer Biol Ther. 2024;25:2306674.
    PubMed         Abstract available


    Cancer Cell Int

  20. CHEN X, Dong X, Li H, Wu T, et al
    RNA-binding proteins signature is a favorable biomarker of prognosis, immunotherapy and chemotherapy response for cervical cancer.
    Cancer Cell Int. 2024;24:80.
    PubMed         Abstract available

  21. LUO L, Wang M, Li X, Luo C, et al
    Correction: A novel mechanism by which ACTA2-AS1 promotes cervical cancer progression: acting as a ceRNA of miR-143-3p to regulate SMAD3 expression.
    Cancer Cell Int. 2024;24:76.
    PubMed        


    Chin Herb Med

  22. CHEN Y, Chen S, Chen K, Ji L, et al
    Magnolol and 5-fluorouracil synergy inhibition of metastasis of cervical cancer cells by targeting PI3K/AKT/mTOR and EMT pathways.
    Chin Herb Med. 2023;16:94-105.
    PubMed         Abstract available


    Clin Cancer Res

  23. LOU H, Cai H, Huang X, Li G, et al
    Cadonilimab combined with chemotherapy with or without bevacizumab as first-line treatment in recurrent or metastatic cervical cancer (COMPASSION-13): a phase 2 study.
    Clin Cancer Res. 2024 Feb 19. doi: 10.1158/1078-0432.CCR-23-3162.
    PubMed         Abstract available


    Cureus

  24. G SN, Sssn R, Chaturvedula L, Adole P, et al
    Deoxyribose Nucleic Acid Damage and Its Association With Plasma Malondialdehyde Levels Among Patients With Cervical Cancer: A Case-Control Study.
    Cureus. 2024;16:e52600.
    PubMed         Abstract available

  25. DURA MC, Akturk H, Aslan O, Yildiz S, et al
    Human Papillomavirus Infection (HPV) Prevalence in the Black Sea Region of Turkey: Primary HPV Screening for Cervical Cancer.
    Cureus. 2024;16:e52615.
    PubMed         Abstract available


    Curr Med Imaging

  26. GAO F, Qian T, Sun M, Lu Y, et al
    MRI Plain Scan: A Tool in the Management of Cervical Cancer during Pregnancy.
    Curr Med Imaging. 2024;20:1-8.
    PubMed         Abstract available


    Data Brief

  27. YADAV R, Chauhan MB, Yadav C, Ranga S, et al
    Awareness data on cervical cancer among females of rural and urban areas of Haryana, India.
    Data Brief. 2024;53:110168.
    PubMed         Abstract available


    Ethiop J Health Sci

  28. AKINNIBOSUN O, Abakpa OG, Ujoh AJ, Oche DA, et al
    Knowledge, Attitudes and Practices among Women of Reproductive Age on Human Papillomavirus Infection, Cervical Cancer and Vaccination in Otukpo, Nigeria.
    Ethiop J Health Sci. 2024;34:15-26.
    PubMed         Abstract available


    Eur J Cancer

  29. TANAKA LF, Schoffer O, Schriefer D, Schauberger G, et al
    An audit of 1632 routinely collected cervical cancer screening smears from 398 women in Germany: Results from the TeQaZ Study.
    Eur J Cancer. 2024;201:113915.
    PubMed         Abstract available


    Expert Opin Biol Ther

  30. GREENMAN M, McNamara B, Mutlu L, Santin AD, et al
    Targeting cervical cancer with anti-PD-1 antibodies: what's new?
    Expert Opin Biol Ther. 2024 Feb 23. doi: 10.1080/14712598.2024.2323596.
    PubMed        


    Fam Community Health

  31. BAEKER BISPO JA, Goo I, Ashad-Bishop K, Kobetz E, et al
    Does Neighborhood Social Cohesion Influence Participation in Routine Cancer Screening? Findings From a Representative Sample of Adults in South Florida.
    Fam Community Health. 2024;47:130-140.
    PubMed         Abstract available


    Front Cardiovasc Med

  32. GE J, Weng C, Zhao J, Yuan D, et al
    Upper extremity phlegmasia cerulea dolens complicating supra vena cava embolism in a cervical cancer patient: case report.
    Front Cardiovasc Med. 2024;11:1351358.
    PubMed         Abstract available


    Front Med (Lausanne)

  33. WU F, Zhang R, Li F, Qin X, et al
    Radiomics analysis based on multiparametric magnetic resonance imaging for differentiating early stage of cervical cancer.
    Front Med (Lausanne). 2024;11:1336640.
    PubMed         Abstract available


    Front Microbiol

  34. FONG AMARIS WM, de Assumpcao PP, Valadares LJ, Moreira FC, et al
    Microbiota changes: the unseen players in cervical cancer progression.
    Front Microbiol. 2024;15:1352778.
    PubMed         Abstract available


    Front Public Health

  35. CARMACK C, Roncancio A, Coleman TM, McKay S, et al
    Concept mapping sociocultural aspects of cervical cancer prevention among African American women.
    Front Public Health. 2024;11:1311286.
    PubMed         Abstract available


    Gynecol Oncol

  36. NASIOUDIS D, Gysler S, Latif N, Cory L, et al
    Molecular landscape of ERBB2/HER2 gene amplification among patients with gynecologic malignancies; clinical implications and future directions.
    Gynecol Oncol. 2023;180:1-5.
    PubMed         Abstract available

  37. ROOF KA, Wichmann HK, Carlton LJ, Nguyen ML, et al
    Factors associated with loss to follow up after abnormal cervical cancer screening in pregnancy.
    Gynecol Oncol. 2024;185:46-50.
    PubMed         Abstract available


    Gynecol Oncol Rep

  38. SHAFFI AF, Odongo EB, Itsura PM, Tonui PK, et al
    Cervical cancer management in a low resource setting: A 10-year review in a tertiary care hospital in Kenya.
    Gynecol Oncol Rep. 2024;51:101331.
    PubMed         Abstract available


    Hum Vaccin Immunother

  39. STEFANOS R, Lewis RM, Querec TD, Gargano JW, et al
    High impact of quadrivalent human papillomavirus vaccine across racial/ethnic groups: National Health and Nutrition Examination Survey, 2003-2006 and 2015-2018.
    Hum Vaccin Immunother. 2024;20:2308378.
    PubMed         Abstract available


    Int J Gen Med

  40. MITOMA T, Maki J, Ooba H, Ogawa C, et al
    Association of Regular Cervical Cancer Screening with Socioeconomic, COVID-19 Infection and Vaccine Status Among Japanese Population: Cohort Observational Study.
    Int J Gen Med. 2024;17:541-551.
    PubMed         Abstract available


    Int J Gynecol Cancer

  41. BIZZARRI N, Obermair A, Hsu HC, Chacon E, et al
    Consensus on surgical technique for sentinel lymph node dissection in cervical cancer.
    Int J Gynecol Cancer. 2024 Feb 20:ijgc-2023-005151.
    PubMed         Abstract available


    Int J Surg

  42. ZHANG J, Qiu H, Qing Y, Hu Y, et al
    A commentary on "Local excision as a viable alternative to c-stage cervical cancer in women of reproductive age: a population-based cohort study".
    Int J Surg. 2024 Feb 21. doi: 10.1097/JS9.0000000000001218.
    PubMed        


    Int Wound J

  43. HAMID HA, Lin X, Qin YK, Akim AM, et al
    Best practices for managing malodorous and infected wounds in advanced cervical cancer.
    Int Wound J. 2024;21:e14574.
    PubMed         Abstract available


    J Cancer Res Clin Oncol

  44. GUO S, Chen P, Yang Y, Wei W, et al
    Tumor-to-stroma cd8(+) t cells ratio combined with cancer-associated fibroblasts: an innovative approach to predicting lymph node metastases of cervical cancer.
    J Cancer Res Clin Oncol. 2024;150:93.
    PubMed         Abstract available


    J Cancer Res Ther

  45. SOOKAROMDEE P, Wiwanitkit V
    Coverage rate of cervical cytology and HPV DNA test for cervix cancer screening: Reappraisal on impact of COVID-19 outbreak.
    J Cancer Res Ther. 2023;19.
    PubMed        

  46. AKRAM M, Khazir M, Khan M, Afrose R, et al
    Age-wise cancer incidence in western Uttar Pradesh in India: An observational study.
    J Cancer Res Ther. 2023;19.
    PubMed         Abstract available

  47. PAUL A, Dutta P, Basu K
    Assessment and clinicopathological correlation of p16 expression in cervical squamous cell carcinoma of Indian population: Diagnostic implications.
    J Cancer Res Ther. 2023;19:2012-2017.
    PubMed         Abstract available

  48. PURI I, Sharma R, Dewan D, Angurana S, et al
    Sexual function status after adjuvant radiation including vaginal cuff brachytherapy in survivors of cancer cervix.
    J Cancer Res Ther. 2023;19:1721-1724.
    PubMed         Abstract available

  49. AZAK C, Kavak G, Ertan F, Alioglu F, et al
    The effect of lower urinary tract substructure doses on side effects of cervical cancer image-guided adaptive brachytherapy.
    J Cancer Res Ther. 2023;19:1825-1830.
    PubMed         Abstract available

  50. DATKHILE KD, Patil SR, Patil MN, Durgawale PP, et al
    Genetic polymorphisms of CYP1A, CYP1B, CYP2C and risk of cervical cancer among rural population of Maharashtra: Findings from a hospital-based case-control study.
    J Cancer Res Ther. 2023;19:1925-1930.
    PubMed         Abstract available


    J Gynecol Oncol

  51. YOO JG, Lee SJ, Nam EJ, No JH, et al
    Clinical practice guidelines for cervical cancer: the Korean Society of Gynecologic Oncology guidelines.
    J Gynecol Oncol. 2024 Feb 13. doi: 10.3802/jgo.2024.
    PubMed         Abstract available


    J Hematop

  52. MINGOLA P, Alshomrani A, Greiner T
    Anaplastic large cell lymphoma presenting as a mass in the uterine cervix: a case report.
    J Hematop. 2024;17:23-26.
    PubMed         Abstract available


    J Med Screen

  53. FOGH JORGENSEN S, Kellen E, Haelens A, Herck KV, et al
    How follow-up rates in cervical cancer screening depend on organizational factors: A comparison of two population-based organized screening programmes.
    J Med Screen. 2024 Feb 21:9691413241231440. doi: 10.1177/09691413241231440.
    PubMed         Abstract available

  54. YUILL S, Egger S, Smith MA, Velentzis L, et al
    Participation in the national cervical screening programme among women from New South Wales, Australia, by place of birth and time since immigration: A data linkage analysis using the 45 and up study.
    J Med Screen. 2024;31:35-45.
    PubMed         Abstract available


    J Med Virol

  55. PRETI M, Boldorini R, Gallio N, Cavagnetto C, et al
    Human papillomavirus genotyping in high-grade vaginal intraepithelial neoplasia: A multicentric Italian study.
    J Med Virol. 2024;96:e29474.
    PubMed         Abstract available


    J Nutr

  56. PEITZ JG, Adebamowo CA, Adebamowo SN
    Association between Serum Folate and Vaginal High-Risk Human Papillomavirus Infections in United States Women.
    J Nutr. 2024;154:583-589.
    PubMed         Abstract available


    J Robot Surg

  57. MICHA JP, Rettenmaier MA, Bohart RD, Goldstein BH, et al
    Current analysis of the survival implications for minimally invasive surgery in the treatment of early-stage cervix cancer.
    J Robot Surg. 2024;18:80.
    PubMed         Abstract available


    JCO Glob Oncol

  58. NDARUKWA S, Flores JA, Rosenblatt E, Berger D, et al
    Brachytherapy Workflow Practices: Analysis of Different Workflow Scenarios in Patients With Cervical Cancer and Impact on IGBT Implementation-An IAEA Study.
    JCO Glob Oncol. 2024;10:e2300336.
    PubMed         Abstract available


    Jpn J Clin Oncol


  59. Correction to: Quality of life but not cachexia definitions are associated with overall survival in women with cervical cancer: a STROBE-compliant cohort study.
    Jpn J Clin Oncol. 2024 Feb 15:hyae023. doi: 10.1093.
    PubMed        


    Lancet Glob Health

  60. FOKOM-DEFO V, Dille I, Fokom-Domgue J
    Single dose HPV vaccine in achieving global cervical cancer elimination.
    Lancet Glob Health. 2024;12:e360-e361.
    PubMed        


    Lasers Med Sci

  61. CAO Y, Xiong J, Du Y, Tang Y, et al
    Raman spectroscopy combined with multivariate statistical algorithms for the simultaneous screening of cervical and breast cancers.
    Lasers Med Sci. 2024;39:68.
    PubMed         Abstract available


    Mol Oncol

  62. ZHENG H, Liu M, Shi S, Huang H, et al
    MAP4K4 and WT1 mediate SOX6-induced cellular senescence by synergistically activating the ATF2-TGFbeta2-Smad2/3 signaling pathway in cervical cancer.
    Mol Oncol. 2024 Feb 21. doi: 10.1002/1878-0261.13613.
    PubMed         Abstract available


    N Z Med J

  63. INGAMELLS S, Bell R, Nip J, Innes C, et al
    Perceived barriers to self-collected HPV testing for cervical cancer screening, and knowledge of HPV: a survey of primary healthcare smear-takers across Aotearoa New Zealand.
    N Z Med J. 2024;137:57-76.
    PubMed         Abstract available


    Oncol Lett

  64. ZHANG H, Zhang R, Zhang G, Liu W, et al
    [Retracted] Clinical significance of miR?1298 in cervical cancer and its biological function in vitro.
    Oncol Lett. 2024;27:150.
    PubMed         Abstract available


    PLoS One

  65. VARON ML, Geng Y, Fellman BM, Troisi C, et al
    Interventions to increase follow-up of abnormal cervical cancer screening results: A systematic literature review and meta-analysis.
    PLoS One. 2024;19:e0291931.
    PubMed         Abstract available


    Public Health

  66. OLTHOF EMG, Aitken CA, Siebers AG, van Kemenade FJ, et al
    Resilience of the Dutch HPV-based cervical screening programme during the COVID-19 pandemic.
    Public Health. 2024;227:42-48.
    PubMed         Abstract available


    Rev Med Virol

  67. ASHOK G, Basu S, Priyamvada P, Anbarasu A, et al
    Coinfections in human papillomavirus associated cancers and prophylactic recommendations.
    Rev Med Virol. 2024;34:e2524.
    PubMed         Abstract available


    Sci Rep

  68. TESFAYE E, Kumbi B, Mandefro B, Hemba Y, et al
    Prevalence of human papillomavirus infection and associated factors among women attending cervical cancer screening in setting of Addis Ababa, Ethiopia.
    Sci Rep. 2024;14:4053.
    PubMed         Abstract available


    Virulence

  69. ZOU Q, Wu Y, Zhang S, Li S, et al
    Escherichia coli and HPV16 coinfection may contribute to the development of cervical cancer.
    Virulence. 2024;15:2319962.
    PubMed         Abstract available


    Womens Health Issues

  70. PERKINS RB, Fuzzell L, Lake P, Brownstein NC, et al
    Factors Associated With Guideline-concordant and Excessive Cervical Cancer Screening: A Mixed Methods Study.
    Womens Health Issues. 2024 Feb 20:S1049-3867(24)00001.
    PubMed         Abstract available


    World J Surg Oncol

  71. WANG T, Li YY, Ma NN, Wang PA, et al
    A MRI radiomics-based model for prediction of pelvic lymph node metastasis in cervical cancer.
    World J Surg Oncol. 2024;22:55.
    PubMed         Abstract available


    Zhonghua Fu Chan Ke Za Zhi

  72. LIU Q, Sun YX, Liu KJ, Li PQ, et al
    [Oncological outcomes of laparoscopic radical trachelectomy for early stage cervical cancer].
    Zhonghua Fu Chan Ke Za Zhi. 2024;59:135-142.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.